Plasminogen intravenous (Shenzhen Weiguang Biological)

人纤溶酶原（深圳市卫光生物）

Report date: 2023/08/22 10:27:00

Base Information

Drug NamePlasminogen intravenous (Shenzhen Weiguang Biological)
Drug Alias Nameplasminogen, human-tvmhRYPLAZIM
ClassificationBiologics > Blood components
Mechanisms of ActionPlasminogen replacements
TargetsPlasminogen
Therapy Area/IndicationsType I plasminogen deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen Weiguang Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Weiguang Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsType I plasminogen deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A